| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.09 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |